FDA Inspection 1191828 — Biotest Pharmaceuticals Corporation
The FDA completed an inspection of Biotest Pharmaceuticals Corporation on November 18, 2022 in Marietta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 18, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Marietta, GA (United States)